Condition: Arthritis, Psoriatic · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to evaluate the efficacy of icotrokinra compared to placebo in participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Arthritis and Rheumatism Associates ARA Jonesboro | Jonesboro, Arkansas, United States | — |
| Omega Research Consultants | DeBary, Florida, United States | — |
| Integral Rheumatology And Immunology Specialists | Plantation, Florida, United States | — |
| Clinical Research of West Florida | Tampa, Florida, United States | — |
| Willow Rheumatology and Wellness PLLC | Willowbrook, Illinois, United States | — |
| Joint and Muscle Research Institute | Charlotte, North Carolina, United States | — |
| Altoona Center For Clinical Research | Duncansville, Pennsylvania, United States | — |
| Arthritis and Rheumatology Research Institute | Allen, Texas, United States | — |
| Naiara Alvarez MD Integrative Rheumatology of South TX | Harlingen, Texas, United States | — |
| Cosultorios Reumatologógicos Pampa | Buenos Aires, Argentina | — |
| Mindout Research | Buenos Aires, Argentina | — |
| Hospital Central Militar Cirujano Mayor Dr Cosme Argerich | Buenos Aires, Argentina | — |
+ 143 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.